One Center's Oversized Impact on Drug Development and Clinical Trials
Newswise — When pharmaceutical companies want to make their clinical trials faster and more efficient, they look at data compiled by the Tufts Center for the Study of Drug Development (CSDD). When the U.S. Food and Drug Administration (FDA) wants to know …